603718 海利生物
按盤價 
6.250 +0.030 (+0.482%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.314 | 12.326 | 5.334 | 11.334 | 5.219 |
| 總資產報酬率 ROA (%) | 1.120 | 9.825 | 3.964 | 7.242 | 2.967 |
| 投入資產回報率 ROIC (%) | 1.283 | 11.854 | 5.051 | 10.793 | 5.012 | 邊際利潤分析 |
| 銷售毛利率 (%) | 74.106 | 60.204 | 51.394 | 58.969 | 55.767 |
| 營業利潤率 (%) | 29.416 | 64.391 | 22.919 | 23.309 | 16.482 |
| 息稅前利潤/營業總收入 (%) | 26.719 | 74.197 | 24.417 | 46.493 | 19.928 |
| 淨利潤/營業總收入 (%) | 25.125 | 67.014 | 20.776 | 36.898 | 13.149 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.294 | 14.352 | -12.366 | 6.497 | 34.243 |
| 價值變動淨收益/利潤總額(%) | 7.003 | 69.982 | 101.072 | 8.615 | 62.819 |
| 營業外收支淨額/利潤總額(%) | -0.255 | 16.140 | 1.521 | 46.711 | -0.179 | 償債能力分析 |
| 流動比率 (X) | 7.633 | 6.901 | 1.349 | 2.073 | 1.456 |
| 速動比率 (X) | 6.917 | 6.352 | 1.102 | 1.622 | 1.243 |
| 資產負債率 (%) | 5.876 | 6.768 | 29.133 | 26.630 | 46.467 |
| 帶息債務/全部投入資本 (%) | 1.097 | 0.843 | 0.619 | -2.041 | -13.039 |
| 股東權益/帶息債務 (%) | 8,899.829 | 11,585.741 | 15,234.977 | -4,661.548 | -731.025 |
| 股東權益/負債合計 (%) | 1,447.640 | 1,262.056 | 251.985 | 282.786 | 117.354 |
| 利息保障倍數 (X) | -10.192 | -28.674 | 21.344 | 16.889 | 5.735 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 194.939 | 128.418 | 136.280 | 112.325 | 77.648 |
| 存貨周轉天數 (天) | 404.904 | 263.391 | 381.076 | 420.438 | 302.978 |
| 備註： | 即時報價更新時間為 12/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
